Medherant

Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer

Coventry, UK, 8th May 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, has appointed Laboratoires Plasto Santé to manufacture its first drug delivery...
Vygon Group

Enteral feeding: Vygon Group launches safe-enteral.com

Vygon is keen to raise awareness amongst medical staff about the benefits of new standardized enteral connectors and the potential risks when used in premature neonates Ecouen, France, April 25, 2017 – Vygon, the single-use...
Domain Therapeutics

Domain Therapeutics and Pfizer Inc. enter into collaboration agreement on bioSensAll™

Strasbourg, France, and Montreal, Canada, April 25, 2017 - Domain Therapeutics, a France- and Quebec-based biopharmaceutical company specializing in the research and development of new drug candidates that target G protein-coupled receptors (GPCRs), today...
Pharmaceutical

California Presses Forward In Fight To Regulate Pharmaceutical Companies

In November, California voters defeated a ballot proposal that would have given state government more control over drug prices. It was a victory for pharmaceutical companies, which spent more than $100 million campaigning against the measure. Now the industry...
Glenmark

Glenmark Gets USFDA Nod For Anti-Cholesterol Drug

Drug firm Glenmark Pharmaceuticals today said it has received final approval from the USFDA for its generic version of Fenofibrate capsules used for lowering cholesterol. The company has been granted final approval by the United...
abbott

Abbott’s Stent Faces Another Storm, This Time On Safety

Even as healthcare major Abbott's bio-absorable stent ‘Absorb' battles price control challenges in India, another storm seems to be blowing in from Europe. The healthcare multinational has sent a letter to doctors in Europe informing...
ATUM

ATUM Launches Cell-Line Development Service

Newark, USA, 10th April 2017 / ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company’s proprietary Leap-In Transposase genome engineering tools.  ATUM...
Ocrevus

USFDA Approved Ocrevus To Treat Multiple Sclerosis

THERAPEUTIC ADVANCE The United States Food and Drug Administration has approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug...
Fosun Pharmaceuticals

FIPB Clears Fosun – Gland Pharma Deal

Shanghai Fosun Pharmaceuticals (Group) Co. Ltd has received approval from Foreign Investment Promotion Board (FIPB) to pick up a majority stake in Hyderabad-based Gland Pharma Ltd. The China-based pharmaceuticals company had agreed to acquire an...
Indian pharmaceuticals

Indian Pharmaceuticals M&A Deals Touch $4.6 Billion In 2016

Indian pharmaceuticals sector witnessed 51 deals being announced in the year 2016, with aggregate disclosed deal value of $4.6 billion. Unlike the trend in the previous years, outbound and domestic transactions drove most of...